ClinicalTrials.gov term: Diabetes Mellitus, Type 2
133 trials changed in the last 30 days: 2 stopped, 53 with notable changes, 78 with minor changes only.
Withdrawn before enrolling
Sun Yat-sen UniversityNot applicable NCT07786571 Registry history of NCT07786571 on ClinicalTrials.gov (opens the registry)
Trial status changed: Not Yet Recruiting → Suspended
University of MiamiPhase 4 NCT07636161 Registry history of NCT07636161 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Mar 20, 2026 to Nov 14, 2026
Also in this update: Enrollment closed, study ongoing
BrightGene Bio-Medical Technology Co., Ltd.Phase 3 NCT06716216 Registry history of NCT06716216 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 29, 2025 to Nov 14, 2026
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Aug 25, 2026 to Nov 14, 2026
BrightGene Bio-Medical Technology Co., Ltd.Phase 3 NCT06716203 Registry history of NCT06716203 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 31, 2026 to Apr 30, 2027
Also in this update: Enrollment closed, study ongoing; Final enrollment: 152 participants (planned 477)
BrightGene Bio-Medical Technology Co., Ltd.Phase 3 NCT07064486 Registry history of NCT07064486 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Mar 30, 2027 to Dec 30, 2027
Also in this update: Trial sites expanded: 12 → 27 locations; Study completion pushed from May 1, 2027 to Sep 30, 2029; and 4 more changes in the last 30 days
Morphic Medical Inc.Not applicable NCT04101669 Registry history of NCT04101669 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 4, 2027 to Apr 6, 2028
AstraZenecaPhase 3 NCT07775404 Registry history of NCT07775404 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Nov 27, 2026 to Feb 5, 2028
Also in this update: Enrollment increased: 240 → 330 participants; Trial sites reduced: 50 → 46 locations
Hoffmann-La RochePhase 2 NCT07112872 Registry history of NCT07112872 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 6, 2025 to Jun 2027
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jun 6, 2025 to Aug 2027
Nimble Science Ltd.Not specified NCT05633706 Registry history of NCT05633706 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2026 to Oct 2028
Also in this update: Primary endpoint(s) modified
Chong Kun Dang PharmaceuticalNot specified NCT06838286 Registry history of NCT06838286 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Sep 2027
Also in this update: Study completion pushed from Mar 2027 to Sep 2027
Johns Hopkins UniversityNot applicable NCT06364644 Registry history of NCT06364644 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 1, 2027 to Dec 1, 2027
Also in this update: Study completion pushed from Nov 1, 2027 to Dec 1, 2027
Medical College of WisconsinPhase 2 NCT06031428 Registry history of NCT06031428 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jan 15, 2026 to Jan 15, 2027
Also in this update: Study completion pushed from Jan 15, 2027 to Mar 15, 2027
Odense University HospitalPhase 2 NCT06050577 Registry history of NCT06050577 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Feb 2030 to Dec 2030
Also in this update: Start date pushed from Aug 7, 2026 to Oct 12, 2026; Study completion pushed from Feb 2030 to Dec 2031
University of Colorado, DenverEarly Phase 1 NCT07409714 Registry history of NCT07409714 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Feb 28, 2028 to Jul 29, 2029
Also in this update: Primary endpoint(s) modified; Enrollment reduced: 15000 → 5000 participants
University Hospital Southampton NHS Foundation TrustNot applicable NCT06803771 Registry history of NCT06803771 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 30, 2026 to Nov 30, 2026
Also in this update: Enrollment closed, study ongoing
Pennington Biomedical Research CenterNot applicable NCT05958368 Registry history of NCT05958368 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 30, 2026 to Jun 30, 2027
University of PennsylvaniaNot applicable NCT04024631 Registry history of NCT04024631 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Trial status changed: Not Yet Recruiting → Active, Not Recruiting
Novo Nordisk A/SNot specified NCT07781371 Registry history of NCT07781371 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Sponsor changed: [Redacted] to Astellas Pharma Inc; Results posted: Sep 30, 2026
Astellas Pharma IncNot specified NCT06156696 Registry history of NCT06156696 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Linkoeping UniversityNot specified NCT07312136 Registry history of NCT07312136 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion pushed from Apr 2027 to Oct 2027
Alveus Therapeutics, Inc.Phase 1 NCT07399678 Registry history of NCT07399678 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Sep 30, 2026 to Aug 30, 2026
Vincentage Pharma Co., LtdPhase 1 NCT07349381 Registry history of NCT07349381 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Eli Lilly and CompanyPhase 2 NCT07215559 Registry history of NCT07215559 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of May 31, 2026 to Sep 30, 2025; Final enrollment: 50 participants (planned 70)
HiDO TechnologiesPhase 2 NCT06691256 Registry history of NCT06691256 on ClinicalTrials.gov (opens the registry)
Trial completed
Carmot Therapeutics, Inc.Phase 2 NCT06628362 Registry history of NCT06628362 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Antag TherapeuticsPhase 2 NCT07724340 Registry history of NCT07724340 on ClinicalTrials.gov (opens the registry)
Trial completed
Eli Lilly and CompanyPhase 2 NCT06603571 Registry history of NCT06603571 on ClinicalTrials.gov (opens the registry)
Trial completed
AstraZenecaPhase 2 NCT06851858 Registry history of NCT06851858 on ClinicalTrials.gov (opens the registry)
Trial completed
Ascletis Pharma (China) Co., LimitedPhase 2 NCT07321678 Registry history of NCT07321678 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
BayerNot specified NCT07232537 Registry history of NCT07232537 on ClinicalTrials.gov (opens the registry)
Trial completed
Steno Diabetes Center CopenhagenNot applicable NCT05768958 Registry history of NCT05768958 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 20 participants (planned 15)
Columbia UniversityPhase 1 NCT06592261 Registry history of NCT06592261 on ClinicalTrials.gov (opens the registry)
Trial status changed: Unknown → Completed
Also in this update: Primary completion date changed from estimate of Dec 25, 2024 to Mar 26, 2025
Vedic Lifesciences Pvt. Ltd.Not applicable NCT06496893 Registry history of NCT06496893 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 238038 participants (planned 150000)
BayerNot specified NCT06608212 Registry history of NCT06608212 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Chipscreen Biosciences, Ltd.Not applicable NCT07519265 Registry history of NCT07519265 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Jun 29, 2026 to May 26, 2026
Chipscreen Biosciences, Ltd.Not applicable NCT07412015 Registry history of NCT07412015 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Apr 30, 2029 to May 31, 2029
BayerNot specified NCT07554469 Registry history of NCT07554469 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 30, 2026 to Oct 31, 2026
BayerNot specified NCT06763146 Registry history of NCT06763146 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 23, 2026 to Nov 30, 2026
And 2 more changes in the last 30 days
Boehringer IngelheimNot specified NCT05882071 Registry history of NCT05882071 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Aug 2026 to Oct 1, 2025
HealthPartners InstituteNot applicable NCT05222815 Registry history of NCT05222815 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Apr 2026 to Sep 28, 2026; Final enrollment: 3392 participants (planned 400)
LMC Diabetes & Endocrinology Ltd.Not specified NCT07424430 Registry history of NCT07424430 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Oct 14, 2026 to Sep 3, 2025
Beijing Chao Yang HospitalNot applicable NCT06639425 Registry history of NCT06639425 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 2026 to Mar 2027
Eli Lilly and CompanyPhase 1 NCT06945406 Registry history of NCT06945406 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 19 participants (planned 80)
University of MichiganNot applicable NCT06574035 Registry history of NCT06574035 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Aug 2026 to Jun 30, 2026; Final enrollment: 79 participants (planned 90)
Monash UniversityNot applicable NCT07091162 Registry history of NCT07091162 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 2027 to Dec 10, 2027
Also in this update: Study completion pushed from Dec 31, 2027 to Jun 2028
RxFunction Inc.Not applicable NCT06959277 Registry history of NCT06959277 on ClinicalTrials.gov (opens the registry)
Trial completed
Medical University of GrazNot specified NCT06605859 Registry history of NCT06605859 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Sep 15, 2025 to Jan 15, 2026; Final enrollment: 731 participants (planned 500)
Medical University of GrazNot specified NCT06605872 Registry history of NCT06605872 on ClinicalTrials.gov (opens the registry)
Trial completed
University of PaviaNot applicable NCT07069166 Registry history of NCT07069166 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 1, 2026 to Sep 17, 2026
Esbjerg Hospital - University Hospital of Southern DenmarkNot applicable NCT06790225 Registry history of NCT06790225 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Mar 30, 2028 to Aug 28, 2026; Final enrollment: 44 participants (planned 120)
University of North Carolina, Chapel HillNot applicable NCT07126587 Registry history of NCT07126587 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary and study completion pushed from Aug 1, 2026 to Dec 31, 2026
Centre for Addiction and Mental HealthNot applicable NCT06251635 Registry history of NCT06251635 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion pushed from Jul 31, 2026 to Nov 15, 2026; Study completion pushed from Jul 31, 2026 to Nov 17, 2026
Daniel Chernavvsky, MDNot applicable NCT07063420 Registry history of NCT07063420 on ClinicalTrials.gov (opens the registry)
Trial completed
University of Alabama at BirminghamNot applicable NCT05288452 Registry history of NCT05288452 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Sep 2027 to May 19, 2026; Final enrollment: 53 participants (planned 45)
Centre Hospitalier Universitaire DijonNot applicable NCT04940962 Registry history of NCT04940962 on ClinicalTrials.gov (opens the registry)
Trial completed
Brigham and Women's HospitalNot specified NCT07390110 Registry history of NCT07390110 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Dec 2026
University of MichiganNot specified NCT06007404 Registry history of NCT06007404 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 1, 2026 to Dec 31, 2026
Rush University Medical CenterNot applicable NCT06643936 Registry history of NCT06643936 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 15 → 20 locations
Hanmi Pharmaceutical Company LimitedPhase 2 NCT07527650 Registry history of NCT07527650 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 58 → 72 locations
And 1 more change in the last 30 days
PfizerPhase 3 NCT07595549 Registry history of NCT07595549 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 204 → 210 locations
Hoffmann-La RochePhase 3 NCT07351058 Registry history of NCT07351058 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 183 → 180 locations
And 1 more change in the last 30 days
PfizerPhase 3 NCT07400653 Registry history of NCT07400653 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 30, 2026 to Apr 30, 2027
Also in this update: Study completion pushed from Nov 30, 2026 to Jul 30, 2027
Abant Izzet Baysal UniversityNot applicable NCT07374744 Registry history of NCT07374744 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 148 → 143 locations
And 1 more change in the last 30 days
Eli Lilly and CompanyPhase 3 NCT07282600 Registry history of NCT07282600 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 30, 2026 to Dec 2026
Ohio State UniversityNot applicable NCT05909046 Registry history of NCT05909046 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Feb 2027
Also in this update: Study completion pushed from Nov 2026 to Apr 2027
Stanford UniversityNot applicable NCT06836479 Registry history of NCT06836479 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Apr 9, 2027
Northwestern UniversityNot applicable NCT04976881 Registry history of NCT04976881 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 30, 2026 to Dec 30, 2026
Johns Hopkins UniversityNot applicable NCT05463289 Registry history of NCT05463289 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 2026 to Feb 28, 2027
The University of Texas Health Science Center at San AntonioNot applicable NCT02969798 Registry history of NCT02969798 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 2026 to Apr 2027
University of ManitobaNot applicable NCT05442840 Registry history of NCT05442840 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 44 → 48 locations
Corcept TherapeuticsPhase 2 NCT03604198 Registry history of NCT03604198 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 37 → 45 locations
AmgenPhase 3 NCT07684144 Registry history of NCT07684144 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Nov 5, 2026 to Sep 28, 2026
BayerNot specified NCT05348733 Registry history of NCT05348733 on ClinicalTrials.gov (opens the registry)
Interventions modified
AstraZenecaPhase 3 NCT07776509 Registry history of NCT07776509 on ClinicalTrials.gov (opens the registry)
Interventions modified
Universidad Antonio NariñoNot applicable NCT07849725 Registry history of NCT07849725 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Dec 2025 to Dec 1, 2026
Also in this update: Primary completion date changed from estimate of Oct 2025 to Dec 20, 2025
Hospital de Clinicas de Porto AlegrePhase 2 NCT04874012 Registry history of NCT04874012 on ClinicalTrials.gov (opens the registry)
Start date changed from estimate of Sep 15, 2026 to Jul 13, 2026
University of Alabama at BirminghamNot applicable NCT07032844 Registry history of NCT07032844 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
BOYDSENSENot applicable NCT06621030 Registry history of NCT06621030 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
MiMedx Group, Inc.Not applicable NCT06600724 Registry history of NCT06600724 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Liom Health AGNot applicable NCT06272136 Registry history of NCT06272136 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Anders Fink-Jensen, MD, DMSciPhase 4 NCT04892199 Registry history of NCT04892199 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Purdue UniversityPhase 1 NCT06596967 Registry history of NCT06596967 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
University of ChileNot applicable NCT06895980 Registry history of NCT06895980 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Universiti Putra MalaysiaNot applicable NCT06614283 Registry history of NCT06614283 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Attikon HospitalNot applicable NCT06611904 Registry history of NCT06611904 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
University of Sao PauloNot specified NCT06607068 Registry history of NCT06607068 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Universiti Putra MalaysiaNot applicable NCT06590519 Registry history of NCT06590519 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Lin HanNot applicable NCT06588127 Registry history of NCT06588127 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Universiti Malaysia SabahNot applicable NCT06587581 Registry history of NCT06587581 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Universitaire Ziekenhuizen KU LeuvenNot specified NCT06577584 Registry history of NCT06577584 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
University Hospital, GhentNot specified NCT06519942 Registry history of NCT06519942 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Central South UniversityNot applicable NCT06428968 Registry history of NCT06428968 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Beijing Anzhen HospitalNot specified NCT06336239 Registry history of NCT06336239 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Methodist Health SystemNot specified NCT05995262 Registry history of NCT05995262 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Mar 2024); last known: Active, Not Recruiting
Metabolic Fitness Association, ItalyNot specified NCT01600924 Registry history of NCT01600924 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2021); last known: Not Yet Recruiting
GCS Ramsay Santé pour l'Enseignement et la RechercheNot applicable NCT04907760 Registry history of NCT04907760 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Recruiting
University of TriesteNot specified NCT06098417 Registry history of NCT06098417 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Active, Not Recruiting
Hospital Universitario de FuenlabradaNot applicable NCT05334173 Registry history of NCT05334173 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-16 | NCT07877948 Comparative Study of Combination Treatment of Bionerv E+ Versus Vitamin B Complex in… | BREGO Life Sciences new | |
| 2026-10-15 | NCT07875010 Wearable NH₃ Sensor for Remote Non-invasive Monitoring and Diagnosis of Diabetic Kidney… | Shanghai Pudong Hospital new | |
| 2026-10-15 | NCT07876401 Effects of Progressive Muscle Relaxation on Anxiety, Depression, and Quality of Life in… | Gul Dural new | |
| 2026-10-15 | NCT07876258 A Study in Type 2 Diabetes Patients Who Are Taking Moderate Dose Insulin, Looking at the… | Aimi Fadilah Mohamad new | Phase 3 |
| 2026-10-13 | NCT07871370 Silymarin Effects on Fatty Liver in Type 2 Diabetics | University of Mosul new | |
| 2026-10-08 | NCT07864805 Electromagnetic Therapy, Peripheral Vascular Diseases, Diabetes | Ashraf Abdelaal new | |
| 2026-10-06 | NCT07861308 Diabetes Distress, Medication Adherence Barriers, Self-Management, and Glycemic Control… | Bilecik Seyh Edebali Universitesi new | |
| 2026-10-01 | NCT07852988 Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes | Silesian Centre for Heart Diseases new | Phase 4 |
| 2026-09-29 | NCT07847177 Nurse-Led Self-Management and Breathing Intervention in Type 2 Diabetes | Aziza Ibrahim Mohamed new | |
| 2026-09-29 | NCT07847593 Probiotics in Obese Patients Treated With Semaglutide | Nordic Biotic Sp. z o.o. new |
| Early Phase 1 | 19 | |
| Phase 1 | 61 | |
| Phase 1/2 | 14 | |
| Phase 2 | 81 | |
| Phase 2/3 | 6 | |
| Phase 3 | 103 | |
| Phase 4 | 113 |
Novo Nordisk A/S (24) · Eli Lilly and Company (19) · AstraZeneca (14) · Assiut University (11) · The University of Texas Health Science Center at San Antonio (11) · Kaiser Permanente (9) · Ohio State University (9) · Region Skane (9) · Steno Diabetes Center Copenhagen (9) · University of Alabama at Birmingham (9)